Careers  |  Sign In  |  Register

Immuno- and Chemotherapy Approach to R/R NSCLC

Lyudmila A. Bazhenova, MD, professor of medicine at UC San Diego Health, discusses the lack of data on chemoimmunotherapy or monotherapy immunotherapy for treatment of ALK-fused non-small cell lung cancer (NSCLC).

Learn more by clicking here.